These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3117828)

  • 1. The usefulness of surrogate markers anti-HBc and ALT for post-transfusion non-A, non-B hepatitis prevention.
    Richard D
    J Virol Methods; 1987 Aug; 17(1-2):105-17. PubMed ID: 3117828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.
    Stevens CE; Aach RD; Hollinger FB; Mosley JW; Szmuness W; Kahn R; Werch J; Edwards V
    Ann Intern Med; 1984 Dec; 101(6):733-8. PubMed ID: 6437308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.
    Koziol DE; Holland PV; Alling DW; Melpolder JC; Solomon RE; Purcell RH; Hudson LM; Shoup FJ; Krakauer H; Alter HJ
    Ann Intern Med; 1986 Apr; 104(4):488-95. PubMed ID: 3006567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occurrence of non-A, non-B post-transfusion hepatitis in heart surgery. Prospective study on the value of the determination of serum alanine aminotransferase and detection of anti-HBc antibodies in blood donors].
    Gayet S; Aymard JP; Janot C; Guillemin C; Briquel ME; Gaucher P; Streiff F
    Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):485-94. PubMed ID: 3108992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated presence of antibody to hepatitis B core antigen in dialysis patients: occurrence of subclinical hepatitis?
    Lai KN; Tam JS; Lai FM; Lin HJ
    Am J Kidney Dis; 1989 May; 13(5):370-6. PubMed ID: 2497642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of alanine aminotransferase and reduction of post-transfusion non-A, non-B hepatitis].
    Hoang B; Simonneau M; Le Xuan P; Guichoux P; Terrier E; Ruffie J
    Rev Fr Transfus Hemobiol; 1989 Apr; 32(2):93-106. PubMed ID: 2502996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surrogate testing for non-A, non-B hepatitis.
    Anderson CC; Contreras M; Barbara JA; Mijovic V
    Lancet; 1987 Apr; 1(8538):912. PubMed ID: 2882303
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis.
    Zuck TF; Sherwood WC; Bove JR
    Transfusion; 1987; 27(2):203-6. PubMed ID: 3103271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group.
    Blajchman MA; Bull SB; Feinman SV
    Lancet; 1995 Jan; 345(8941):21-5. PubMed ID: 7528310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
    Sugg U; Schenzle D; Hess G
    Transfusion; 1988; 28(4):386-8. PubMed ID: 3133848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
    Kline WE
    Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
    [No Abstract]   [Full Text] [Related]  

  • 13. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis.
    Bettigole R; Shastri KA
    J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
    Takano S; Omata M; Ohto M; Nakamura K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
    Biswas R
    Vox Sang; 1989; 56(1):63. PubMed ID: 2492703
    [No Abstract]   [Full Text] [Related]  

  • 16. Alanine aminotransferase, gamma-glutamyltransferase, antibodies to hepatitis B core antigen and antibodies to hepatitis C virus in blood donor screening. A prospective study in Finland.
    Ebeling F
    Vox Sang; 1991; 60(4):219-24. PubMed ID: 1681620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the blood supply. Surrogate testing and transmission of hepatitis C in patients after massive transfusion.
    Morris JA; Wilcox TR; Reed GW; Hunter EB; Wallas CH; Steane EA; Shotts SD; Vitsky JL
    Ann Surg; 1994 May; 219(5):517-25; discussion 525-6. PubMed ID: 7514394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
    Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
    Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis.
    Hoyos M; Sarrión JV; Pérez-Castellanos T; Prieto M; Marty ML; Garrigues V; Berenguer J
    Hepatology; 1989 Mar; 9(3):449-51. PubMed ID: 2493415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.